Education
Ph.D. in Cell, Molecular and Developmental Biology, Johns Hopkins University, 2007.
Current position
Research Teaching Specialist, UMDNJ/CINJ, New Brunswick, NJ.
Publications
-
Dudgeon, C., Shreeram, S., Tanoue, K., Mazur, S., Robinson, R. C., Appella, E. and Bulavin, D. V. Genetic Variants of the Wip1 Phosphatase Increase the Response to DNA Damage. (Submitted, Oncogene).
-
Sun, J., Sun, Q., Brown, M. F., Dudgeon, C., Chandler, J., Xu, X., Shu, Y., Zhang, L. and Yu, J. (2012). The multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMA. PLoS ONE 7(8): e43158.
-
Dudgeon, C., Peng, R., Wang, P., Sebastiani, A., Yu, J. and Zhang, L. (2012). Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3beta and NF-kappaB to suppress tumor cell growth. Oncogene 31(46): 4848-4858.
-
Dudgeon, C., Wang, P., Sun, X., Peng, R., Sun, Q., Yu, J. and Zhang, L. (2010). PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01. Mol Cancer Ther 9(11): 2893-2902.
-
Zhou, G., Dudgeon, C., Li, M., Cao, Y., Zhang, L. and Jin, H. (2010). Molecular cloning of the HGD gene and association of SNPs with meat quality traits in Chinese red cattle. Mol Biol Rep 37(1): 603-611.
-
Wang, P., Qiu, W., Dudgeon, C., Liu, H., Huang, C., Zambetti, G. P., Yu, J. and Zhang, L. (2009). PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ 16(9): 1192-1202.
-
Dudgeon, C. and Yu, J. (2008). Green Tea and PUMA: A Deadly Combination? Cancer Biol Ther 7:727-28.
-
Shreeram, S., Demidov, O. N., Hee, W. K., Yamaguchi, H., Onishi, N., Kek, C., Timofeev, O. N., Dudgeon, C., Fornace, A. J., Anderson, C. W., Minami, Y., Appella, E. and Bulavin, D. V. (2006). Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 23(5): 757-764.
-
Dudgeon, C., Kek, C., Demidov, O. N., Saito, S., Fernandes, K., Diot, A., Bourdon, J. C., Lane, D. P., Appella, E., Fornace, A. J., Jr. and Bulavin, D. V. (2006). Tumor susceptibility and apoptosis defect in a mouse strain expressing a human p53 transgene. Cancer Res 66(6): 2928-2936.
-
Bulavin, D. V., Phillips, C., Nannenga, B., Timofeev, O., Donehower, L. A., Anderson, C. W., Appella, E. and Fornace, A. J., Jr. (2004). Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat Genet 36(4): 343-350.
-
Bulavin, D. V., Demidenko, Z. N., Phillips, C., Moody, S. A. and Fornace, A. J., Jr. (2003). Phosphorylation of Xenopus Cdc25C at Ser285 interferes with ability to activate a DNA damage replication checkpoint in pre-midblastula embryos. Cell Cycle 2(3): 263-266.
-
Bulavin, D. V., Higashimoto, Y., Demidenko, Z. N., Meek, S., Graves, P., Phillips, C., Zhao, H., Moody, S. A., Appella, E., Piwnica-Worms, H. and Fornace, A. J., Jr. (2003). Dual phosphorylation controls Cdc25 phosphatases and mitotic entry. Nat Cell Biol 5(6): 545-551.
-
Bulavin, D. V., Demidov, O. N., Saito, S., Kauraniemi, P., Phillips, C., Amundson, S. A., Ambrosino, C., Sauter, G., Nebreda, A. R., Anderson, C. W., Kallioniemi, A., Fornace, A. J., Jr. and Appella, E. (2002). Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31(2): 210-215.